ATM and acute myeloid leukemia: Although the promoter region of CDKN1A, the gene encoding p21cip1/waf1, is usually not methylated in acute myeloid leukemia (AML), decitabine is capable of inducing its re-expression via induction of DNA damage and activation of the ATM/p53 pathway [14].